Terminated PHASE4 INTERVENTIONAL 1-arm NCT05696392

The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance. (MORPHEUS)

An Open-Label, Single-Arm, Phase 4 Study of Ruxolitinib Cream in Adults With Atopic Dermatitis Experiencing Sleep Disturbance in the United States (MORPHEUS)

Sponsor: Incyte Corporation

Conditions Atopic Dermatitis

Interventions ruxolitinib cream

Updated 22 times since 2023 Last updated: Dec 3, 2025 Started: Mar 16, 2023 Primary completion: Jan 22, 2025 Completion: Jan 22, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The study was terminated due to lack of enrollment.

Other terminated trials from Incyte Corporation

More terminations from Incyte Corporation

Other Atopic Dermatitis trials with similar outcome

Browse all Atopic Dermatitis trials

A PHASE4 clinical study on Atopic Dermatitis, this trial is terminated or withdrawn. The trial is conducted by Incyte Corporation and has accumulated 22 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

22 versions recorded

Jan 2026 — Present [monthly]

Terminated PHASE4
Sep 2025 — Jan 2026 [monthly]

Terminated PHASE4
May 2025 — Sep 2025 [monthly]

Terminated PHASE4

Status: Recruiting → Terminated
Mar 2025 — May 2025 [monthly]

Recruiting PHASE4
Feb 2025 — Mar 2025 [monthly]

Recruiting PHASE4

▶ Show 17 earlier versions

Jan 2025 — Feb 2025 [monthly]

Recruiting PHASE4
Dec 2024 — Jan 2025 [monthly]

Recruiting PHASE4
Oct 2024 — Dec 2024 [monthly]

Recruiting PHASE4
Sep 2024 — Oct 2024 [monthly]

Recruiting PHASE4
Aug 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Jul 2024 — Aug 2024 [monthly]

Recruiting PHASE4
Apr 2024 — Jul 2024 [monthly]

Recruiting PHASE4
Mar 2024 — Apr 2024 [monthly]

Recruiting PHASE4
Feb 2024 — Mar 2024 [monthly]

Recruiting PHASE4
Nov 2023 — Feb 2024 [monthly]

Recruiting PHASE4
Oct 2023 — Nov 2023 [monthly]

Recruiting PHASE4
Sep 2023 — Oct 2023 [monthly]

Recruiting PHASE4
Aug 2023 — Sep 2023 [monthly]

Recruiting PHASE4
Jul 2023 — Aug 2023 [monthly]

Recruiting PHASE4
Jun 2023 — Jul 2023 [monthly]

Recruiting PHASE4
Mar 2023 — Jun 2023 [monthly]

Recruiting PHASE4
Feb 2023 — Mar 2023 [monthly]

Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Incyte Corporation

Data source: Incyte Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Arlington, United States , Boca Raton, United States , Boston, United States , Brooklyn, United States , Burke, United States , Charleston, United States , Clarksville, United States , Coral Gables, United States , Dayton, United States , East Syracuse, United States and 19 more locations